Diana L. Price, PhD is the senior director of neurosciences at Neuropore Therapies where she has lead research efforts supporting drug discovery, preclinical development and translational biomarker studies since 2011. Dr. Price received her doctorate in Neurosciences from the UCSD School of Medicine in 2000. She conducted a postdoctoral appointment from 2000-2003, and then transitioned to an academic research faculty member at the National Center for Microscopy and Imaging Research at UCSD while conducting collaborative multi-scale imaging, behavioral pharmacology and bioinformatics research in pursuit of characterizing translational models of CNS disorders. Dr. Price moved to industry in 2007, with a position at ACADIA Pharmaceuticals as a member of the drug-discovery team for neurological and psychiatric disorders utilizing behavioral pharmacology and neuroanatomical techniques to evaluate drug candidates and provide proof of concept data for preclinical development of Pimavanserin (Nuplazid™) for Parkinson's and Alzheimer's disease psychosis.